These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33011782)

  • 1. Longitudinal Trajectories of Neurocognitive Functioning in Childhood Acute Lymphoblastic Leukemia.
    Partanen M; Phipps S; Russell K; Anghelescu DL; Wolf J; Conklin HM; Krull KR; Inaba H; Pui CH; Jacola LM
    J Pediatr Psychol; 2021 Feb; 46(2):168-178. PubMed ID: 33011782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic pain and neurocognitive functioning in children treated for acute lymphoblastic leukemia.
    Partanen M; Alberts NM; Conklin HM; Krull KR; Pui CH; Anghelescu DA; Jacola LM
    Pain; 2022 Jun; 163(6):1070-1077. PubMed ID: 34813516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
    Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
    Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer.
    Thompson SJ; Leigh L; Christensen R; Xiong X; Kun LE; Heideman RL; Reddick WE; Gajjar A; Merchant T; Pui CH; Hudson MM; Mulhern RK
    J Clin Oncol; 2001 Mar; 19(6):1802-8. PubMed ID: 11251012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.
    Krull KR; Bhojwani D; Conklin HM; Pei D; Cheng C; Reddick WE; Sandlund JT; Pui CH
    J Clin Oncol; 2013 Jun; 31(17):2182-8. PubMed ID: 23650422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
    Hardy KK; Kairalla JA; Gioia AR; Weisman HS; Gurung M; Noll RB; Hinds PS; Hibbitts E; Salzer WL; Burke MJ; Winick NJ; Embry L
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30350. PubMed ID: 37129114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological outcomes of standard risk and high risk patients treated for acute lymphoblastic leukemia on Dana-Farber ALL consortium protocol 95-01 at 5 years post-diagnosis.
    Waber DP; Queally JT; Catania L; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Sallan SE; Silverman LB
    Pediatr Blood Cancer; 2012 May; 58(5):758-65. PubMed ID: 21721112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
    Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
    J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
    Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.
    Conklin HM; Krull KR; Reddick WE; Pei D; Cheng C; Pui CH
    J Natl Cancer Inst; 2012 Sep; 104(18):1386-95. PubMed ID: 22927505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.
    Nassar SL; Conklin HM; Zhou Y; Ashford JM; Reddick WE; Glass JO; Laningham FH; Jeha S; Cheng C; Pui CH
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28130818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
    Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
    BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive subgroups in major depressive disorder.
    Martin DM; Wollny-Huttarsch D; Nikolin S; McClintock SM; Alonzo A; Lisanby SH; Loo CK
    Neuropsychology; 2020 Sep; 34(6):726-734. PubMed ID: 32324004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.